Citations

Clear

9383 citation(s) found for "Thomas, PS".

A-149 Comparison of Mass Spectrometry to Sickle Solubility for Confirmation of Low Percentages of Hemoglobin S
Olson, Thomas P. , Rangan, Aruna , Kandler, René , Pappas, Alex A., Yang, Bin , Herrick, James L., Kandler, R, Zhang, X

Mayo Clinic

Clinical Chemistry | October 2, 2024 | Volume: 70 | Issue: Supplement_1 | Pages: No page available

10.1093/clinchem/hvae106.147 Get It

Abstract Background Hemoglobin S (HbS) causes sickling disorders. In the laboratory, confirmation of HbS in patient samples with varying percentages is essential. Assessment is routinely performed using capillary electrophoresis (CE) and/or high-performance liquid chromatography. Sickle solubility (SS) exploits decreased solubility of HbS under reducing conditions and is a confirmatory test. SS is unreliable with low HbS, elevated HbF, severe anemia, erythrocytosis, hyperglobulinemia, extreme leukocytosis, hyperlipidemia, or increased serum proteins. Infant samples commonly have low percentages of HbS, high HbF, and limited sample volume. Intact globin chain Mass Spectrometry (MS) is used to identify abnormal hemoglobin variants by detecting the mass change (normal α/β/γ mass =15127/15867/15996 amu), respectively). MS has potential advantages in sensitivity and efficiency over SS and requires lower input sample volume. Herein we compare the utility of MS versus SS for confirmation of HbS. Methods Twenty-three EDTA-anticoagulated blood samples containing low percentages of HbS were identified. SS was performed on 30μL washed packed cells (requires 200μL whole blood) per standard methods. Intact Quadrupole Time-of-Flight MS (Accurate-Mass Q-TOF LC/MS 6520, Agilent Technologies, California) was performed using 10μL whole blood sample in acetonitrile solution reagent and results were compared. HbS and HbF levels were assayed by capillary electrophoresis (Sebia, France) per standard methods. Results Select results are summarized in Table 1. SS detected HbS percentages to 4.8% when HbF was low but not 6% HbS when Hb F is high. MS showed no HbF interference and identified HbS peaks (at 15837 amu) down to 3.1%. HbS percentages <3.1 were undetected by both methods. Conclusions Overall, MS was superior to SS for confirming HbS, particularly in samples with low variant percentage and/or elevated HbF. MS is also optimal when sample volume is minimal, such as for infants. Percentages of HbS <3% require methods such as IEF or DNA sequencing for confirmation.
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations
Xie, Zhuoer , Finke, Christy M. , Amundson, Michelle, McCullough, Kristen , LaPlant, Betsy, Mangaonkar, Abhishek A. , Gangat, Naseema , Reichard, Kaaren K. , Elliott, Michelle A. , Patnaik, Mrinal M. , McCullough, Kristen B , LaPlant, Betsy R, Gangat, Naseema , Witzig, T.E. , Patnaik, Mrinal , Xie, Zhuoer , Fernandez, Jenna , Lasho, Terra L. , Witzig, Thomas E.

Mayo Clinic

Blood | October 1, 2024 | Volume: 144 | Issue: 23 | Pages: 2456-2461

10.1182/blood.2024024962 | PMID 39352751 Get It

Abstract This phase 2 trial assessed high-dose IV ascorbic acid in TET2 mutant clonal cytopenia. Eight of 10 patients were eligible for response assessment, with no responses at week 20 by International Working Group Myelodysplasia Syndromes/Neoplasms criteria. This trial was registered at www.clinicaltrials.gov as #NCT03418038.
Clinical outcomes following hospitalization for COVID-19 in patients with cardiac sarcoidosis in the United States: a propensity-matched analysis from national inpatient sample database from April 2020 to December 2021
Mactaggart, Sebastian , Ahmed, Raheel , Riaz, Asma, Ramphul, Kamleshun , Bilal, Maham , Jamil, Yumna , PEKYI-BOATENG, PRINCE KWABLA , Azzu, Alessia , Wells, Athol U. , Sharma, Rakesh, Pekyi-Boateng, Prince K , Ahmed, Raheel , Tabassum, Shehroze , Dulay, Mansimran Singh , Liu, Alexander , Ahmed, Mushood , Sawatari, Hiroyuki , Kouranos, Vasileios , Chahal, C. Anwar A.

Mayo Clinic

Annals of Medicine & Surgery | October 1, 2024 | Volume: 86 | Issue: 10 | Pages: 5696-5703

10.1097/ms9.0000000000002474 | PMID 39359767 Get It

Background: The highly arrhythmogenic nature of cardiac sarcoidosis (CS) leads to high morbidity and mortality, the rates of which may be higher in COVID-19 patients. This study aimed to evaluate the outcomes of CS patients admitted to hospitals with COVID-19. Methods: The study utilised the 2020–2021 National Inpatient Sample database, examining primary COVID-19 cases in adults aged older than or equal to 18 years. Those with CS were identified using ICD-10 code “D86.85” and compared with and without propensity matching (1:10) to those without CS for baseline characteristics and primary outcomes of acute kidney injury (AKI), use of mechanical ventilation, cardiac arrest and mortality. Results: In total, 2 543 912 COVID-19 cases were identified. Before propensity matching, CS patients were more likely to be younger (58.0 vs. 64.0 years, P<0.01), male (64.0% vs. 52.6%, P=0.011), of Black ethnicity (60.0% vs. 15.9%, P<0.01), exhibit higher Charlson Comorbidity Index (CCI) scores (3.00 vs. 1.00, P<0.01) and had a higher incidence of in-hospital cardiac arrest (aOR 2.649, 95% CI 1.366–5.134, P=0.004). After propensity matching (CS, N=95; non-CS, N=875), those with CS were at a statistically significant reduced risk of AKI (aOR 0.484, P=0.01); however, the outcomes of death, cardiac arrest, mechanical ventilation, length of stay (LOS) and healthcare costs did not reach significance. Conclusion: In a propensity-matched cohort admitted with COVID-19, CS patients had a reduced risk of AKI, but comparable LOS, rates of cardiac arrest, mechanical ventilator use, and mortality. Future research is warranted to develop evidence-based guidelines for managing COVID-19 in patients with CS.
Proposed Nutrition Competencies for Medical Students and Physician Trainees
Eisenberg, David M. , Cole, Alexis R. , Maile, Edward J. , Salt, Matthew , Leib, Emily Broad , Findley, Trevor, Massa, Jennifer , Albin, Jaclyn , Alston, Meredith , Barkoukis, Hope , Buckhold, Fred R. , Danoff, Robert, Delichatsios, Helen K., Devries, Stephen , Dewar, Stephanie , Rocco, Jennifer Di , Duggan, Christopher , Frates, Beth, Hansen, Pamela A., Haramati, Aviad , Harlan, Timothy S., Hauser, Michelle E. , Leopold, David , Lewis, Joanna , Locke, Amy , Mann, Joshua R. , McClure, Auden C. , Misra, Saroj, Murano, Tiffany , Pierce-Talsma, Stacey , Potts, Stacy , Reilly, Jo Marie , Ring, Melinda , Sampang, Suzanne, Shafto, Kate, Shiue, Linda, Slusser, Wendelin , Stone, Terri, Studer, Karen , Thomas, Olivia , Trilk, Jennifer L. , Oxentenko, Amy, Armstrong, Elizabeth, Essel, Kofi D. , McWhorter, John Wesley , Oxentenko, Amy S. , Edgar, Laura

Mayo Clinic

JAMA Network Open | September 30, 2024 | Volume: 7 | Issue: 9 | Pages: e2435425

10.1001/jamanetworkopen.2024.35425 | PMID 39348126 Get It

Importance In 2022, the US House of Representatives passed a bipartisan resolution (House of Representatives Resolution 1118 at the 117th Congress [2021-2022]) calling for meaningful nutrition education for medical trainees. This was prompted by increasing health care spending attributed to the growing prevalence of nutrition-related diseases and the substantial federal funding via Medicare that supports graduate medical education. In March 2023, medical education professional organizations agreed to identify nutrition competencies for medical education. Objective To recommend nutrition competencies for inclusion in medical education to improve patient and population health. Evidence Review The research team conducted a rapid literature review to identify existing nutrition-related competencies published between July 2013 and July 2023. Additional competencies were identified from learning objectives in selected nutrition, culinary medicine, and teaching kitchen curricula; dietetic core competencies; and research team–generated de novo competencies. An expert panel of 22 nutrition subject matter experts and 15 residency program directors participated in a modified Delphi process and completed 4 rounds of voting to reach consensus on recommended nutrition competencies, the level of medical education at which they should be included, and recommendations for monitoring implementation and evaluation of these competencies. Findings A total of 15 articles met inclusion criteria for competency extraction and yielded 187 competencies. Through review of gray literature and other sources, researchers identified 167 additional competencies for a total of 354 competencies. These competencies were compiled and refined prior to voting. After 4 rounds of voting, 36 competencies were identified for recommendation: 30 at both undergraduate and graduate levels, 2 at the undergraduate level only, and 4 at the graduate level only. Competencies fell into the following nutrition-related themes: foundational nutrition knowledge, assessment and diagnosis, communication skills, public health, collaborative support and treatment for specific conditions, and indications for referral. A total of 36 panelists (97%) recommended nutrition competencies be assessed as part of licensing and board certification examinations. Conclusions and Relevance These competencies represent a US-based effort to use a modified Delphi process to establish consensus on nutrition competencies for medical students and physician trainees. These competencies will require an iterative process of institutional prioritization, refinement, and inclusion in current and future educational curricula as well as licensure and certification examinations.
Mohs Micrographic Surgery With Melanocytic Immunostains for T1a/b Invasive Melanoma Yields
Kumar, Anagha , Trischman, Thomas , Asamoah, Eucabeth, Vidal, Nahid Y. , Demer, Addison M. , Todd, Austin W.

Mayo Clinic

Dermatologic Surgery | September 30, 2024 | Volume: 51 | Issue: 2 | Pages: 123-126

10.1097/dss.0000000000004414 | PMID 39347647 Get It

BACKGROUND The use of Mohs micrographic surgery with melanocytic immunostains (MMS-I) for cutaneous melanoma is increasing. OBJECTIVE To assess local recurrence, melanoma-specific death rates in patients with invasive melanoma treated with MMS-I. MATERIALS AND METHODS A single-center retrospective review of patients with invasive melanoma treated with MMS-I from January 2008 to December 2018. RESULTS Three hundred fifty-two patients (359 melanomas) were included. The median age was 71 years; most patients were male (252%; 71.6%). Most tumors were T1a/b (341, 95%), H/N (322; 89.7%), and lentigo maligna subtype (281, 78.3%). At a median follow-up of 4.3 years, local recurrence rates were 1.4% (5) and 0.9% (3) among all-stage and T1a/b tumors, respectively. There were 3 melanoma-related deaths (0.9%). CONCLUSION MMS-I is associated with <1% risk of local recurrence and disease-specific mortality for T1a/b melanomas.
Prostate Cancer Progression Modeling Provides Insight into Dynamic Molecular Changes Associated with Progressive Disease States
Chen, Runpu , Tang, Li , Melendy, Thomas , Yang, Le , Goodison, Steve , Sun, Yijun

Mayo Clinic

Cancer Research Communications | September 30, 2024 | Volume: 4 | Issue: 10 | Pages: 2783-2798

10.1158/2767-9764.crc-24-0210 | PMID 39347576 Get It

Abstract Prostate cancer is a significant health concern and the most commonly diagnosed cancer in men worldwide. Understanding the complex process of prostate tumor evolution and progression is crucial for improved diagnosis, treatments, and patient outcomes. Previous studies have focused on unraveling the dynamics of prostate cancer evolution using phylogenetic or lineage analysis approaches. However, those approaches have limitations in capturing the complete disease process or incorporating genomic and transcriptomic variations comprehensively. In this study, we applied a novel computational approach to derive a prostate cancer progression model using multidimensional data from 497 prostate tumor samples and 52 tumor-adjacent normal samples obtained from The Cancer Genome Atlas study. The model was validated using data from an independent cohort of 545 primary tumor samples. By integrating transcriptomic and genomic data, our model provides a comprehensive view of prostate tumor progression, identifies crucial signaling pathways and genetic events, and uncovers distinct transcription signatures associated with disease progression. Our findings have significant implications for cancer research and hold promise for guiding personalized treatment strategies in prostate cancer. Significance: We developed and validated a progression model of prostate cancer using &gt;1,000 tumor and normal tissue samples. The model provided a comprehensive view of prostate tumor evolution and progression.
Digital Education on Hospital Nutrition Diets: What Do Patients Want to Know?
Gutta, Neha , Patel, Dharti , Jamal, Aleena, Qureshi, Fawad , Qureshi, Fawad , Singh, Som Prabh

Mayo Clinic

Nutrients | September 30, 2024 | Volume: 16 | Issue: 19 | Pages: 3314

10.3390/nu16193314 | PMID 39408281 Get It

Introduction: Therapeutic nutrition plays an imperative role during a patient’s hospital course. There is a tremendous body of literature that emphasizes the systematic delivery of information regarding hospital nutrition diets. A major component of delivering healthcare information is the principle of providing quality healthcare information, but this has not yet been investigated on hospital nutrition diets. This study aimed to evaluate the comprehension and readability of patient education materials regarding therapeutic hospital diets. Methodology: The methodology employed the use of publicly available questions regarding hospital nutrition diets and categorized them per Rothwell’s Classification of Questions. Additionally, the questions were extracted online and have an associated digital article linked to the question. These articles underwent analysis for readability scores. Results: This study’s findings reveal that most hospital diets do not meet the recommended grade-reading levels. Conclusions: This underscores the need for healthcare providers to enhance patient education regarding hospital diets. The prevalence of “Fact” questions showcases the importance of clearly explaining diets and dietary restrictions to patients.
251: Cannulation characteristics, complications, and patient outcomes: Experience from a Tertiary care center.
Galvan, Chris E., Jena, Anek , Chaudhary, Sanjay, Kiley, Sean , Sanghavi, Devang , Sareyyüpoğlu, Başar , Thomas, Mathew , Galvan, Francisco, Matos, Nikki , Bhattacharyya, Anirban , Franco, Pablo Moreno , Guru, Pramod

Mayo Clinic

ASAIO Journal | September 28, 2024 | Volume: 70 | Issue: Supplement 4 | Pages: 72-72

10.1097/01.mat.0001070236.95026.e9 Get It

Dynamic functional connectivity via iEEG - fMRI correlation maps
Qadir, Zeeshan , Montoya, Morgan , Jensen, Michael J. , Valencia, Gabriela Ojeda , Miller, Kai J. , Naselaris, Thomas , Hermes, Dora, Huang, Harvey , Jensen, Michael, Worrell, Gregory A. , Kay, Kendrick , Hermes, Dora

Mayo Clinic

Journal of Vision | September 27, 2024 | Volume: 24 | Issue: 10 | Pages: 1304

10.1167/jov.24.10.1304 Get It

The Natural Scenes Dataset: Lessons Learned and What's Next?
Kupers, Eline R. , Durkin, Celia, Curtis, Clayton E. , Naselaris, Thomas , Durkin, Celia , Huang, Harvey , Hermes, Dora , Kay, Kendrick

Mayo Clinic

Journal of Vision | September 27, 2024 | Volume: 24 | Issue: 10 | Pages: 147

10.1167/jov.24.10.147 Get It